£26.00
A high-purity research blend studied in growth-hormone research. Available in 5mg/5mg, with every batch independently tested and dispatched from the UK.
Order before 2pm for same-day dispatch
Standard courier delivery
256-bit SSL
Available strengths
Identity confirmed
Chromatographic purity
Documentation supplied
2–8°C · ~30 days
CJC-1295 (No DAC) Research
Laboratory research on the individual components examines complementary endocrine pathways. CJC-1295 No DAC is associated with GHRH-receptor signalling and pituitary response, while Ipamorelin is studied as the first selective growth-hormone secretagogue (Learn more) acting through the growth-hormone secretagogue receptor. Combined experimental models can therefore examine interactions between GHRH and ghrelin-receptor signalling.
CJC-1295 (No DAC)
Research blend combining a short-acting GHRH analogue with Ipamorelin
10mg vial
≈ 9111.45 g/mol (9.11 kDa)
Lyophilized powder
≥ 99%
2–8°C · ~30 days
HPLC and Mass Spectrometry where analytically appropriate